Russia ... No side effects of the Chinese Corona vaccine on the volunteers

Russian pharmaceutical company Petrovax announced that volunteers had not reported any "side effects" after receiving the Chinese coronavirus vaccine as part of a large-scale clinical trial, and Petrovax launched clinical trials of the third phase of the Chinese candidate vaccine, d5-nCoV, developed by CanSino Biologics and the research arm. For the Chinese Army, on the first group of recruits in Moscow.

And according to The Moscow Times, Russia agreed last month to trials of the third phase of the Chinese vaccine for Corona so far, the company said it has received more than 3,000 applications for the vaccine, which is seen as one of dozens of potential candidates in various stages of development across the country. the world.

The company added that people who were vaccinated with the d5-nCoV vaccine are expected to develop antibodies and a cellular immune response to Coronavirus, the virus that causes Coronavirus disease, and the Russian company said that the participants in the trial will be subject to direct supervision for about a month, with four temporary face-to-face tests. For face, adding that they will also undergo a surveillance check after six months.

The report said that Petrofax expects preliminary results from experiments sometime in November, and the Russian company stated that it plans to produce more than 4 million doses per month this year and up to 10 million doses per month in 2021, once the Chinese vaccine is registered in Russia.